Evolution Wealth Advisors, LLC Insmed Inc Transaction History

Evolution Wealth Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$25.89 - $33.45 $9,501 - $12,276	-367 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$22.46 - $29.47 $12,375 - $16,237	-551 Reduced 60.02%	367 $10,000
Q2 2021 Jul 22, 2021	BUY	$24.17 - $36.01 $5,148 - $7,670	213 Added 30.21%	918 $26,000
Q1 2021 Apr 20, 2021	BUY	$32.28 - $44.3 $1,775 - $2,436	55 Added 8.46%	705 $24,000
Q4 2020 Feb 02, 2021	SELL	$31.45 - $40.54 $9,812 - $12,648	-312 Reduced 32.43%	650 $22,000

Q3 2020 Oct 15, 2020	SELL	$26.0 - $34.5 $2,262 - $3,001	-87 Reduced 8.29%	962 $31,000
Q1 2020 Apr 22, 2020	SELL	$13.63 - $33.98 $654 - $1,631	-48 Reduced 4.38%	1,049 $17,000
Q4 2019 Feb 03, 2020	BUY	$16.12 - $24.98 $15,942 - $24,705	989 Added 915.74%	1,097 $26,000
Q3 2019 Nov 12, 2019	BUY	$15.49 - $25.78 $1,672 - $2,784	108 New	108 $2,000

340

141M

2.25M

3.11M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.74B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.